SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (4427)1/9/1998 1:40:00 AM
From: BigKNY3  Read Replies (3) of 23519
 
TA: I really don't think you responded to my posts. In fact, the FDA is the best drug regulatory agency in the world. Not perfect by far..but still the best. If you disagree, please name that agency. Moreover, the FDA has have taken great strives to improve and has become more responsive to the needs of "us". Thank goodness.

It's nice to see your loyalty to MUSE and Vivus. But, the facts are that 95% of ED patients still prefer to stay home rather than visit their physicians to begin current ED therapy. Given that 80% of ED is an indication of a physical disorder, it is much more serious condition than you indicate. I find it particularly strange that a physician who invests in the ED market has such a low regard for ED patients. Moreover, the Massahusetts Male Aging Study found no correlation between ED and obesity.

Will MUSE find a niche in the marketplace? I believe it might. However, Vivus should realize that they are have "the tape" of the ED market and a new "CD product" is coming soon. How VVUS' management acts in this environment could determine whether their tape is "an 8 track" or a "cassette".

TA,a good evening to you, too!

BigKNY3
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext